CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-18 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award · Non-Qualifed Stock Option (right to buy) | +34,887 | 34,887 | ||
| 2020-02-07 | PREVOZNIK MICHAEL E SVP & General Counsel | Gift | −480 | 38,978 | ||
| 2020-01-02 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −1,543 | $106.52 | $164K | 21,250 |
| 2020-01-02 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +291 | 8,987.83 | ||
| 2020-01-02 | Davis J. E. EVP, General Diagnostics | Exercise or conversion | +65,681 | $71.17 | $4.7M | 102,215 |
| 2020-01-02 | Davis J. E. EVP, General Diagnostics | Exercise or conversion | +77,865 | $66.51 | $5.2M | 180,080 |
| 2020-01-02 | Davis J. E. EVP, General Diagnostics | Sale | −58,258 | $105.46 | $6.1M | 121,822 |
| 2020-01-02 | Davis J. E. EVP, General Diagnostics | Sale | −7,423 | $106.51 | $791K | 114,399 |
| 2020-01-02 | Davis J. E. EVP, General Diagnostics | Sale | −69,003 | $105.45 | $7.3M | 45,396 |
| 2020-01-02 | Davis J. E. EVP, General Diagnostics | Sale | −8,853 | $106.51 | $943K | 36,543 |
| 2020-01-02 | Davis J. E. EVP, General Diagnostics | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −65,681 | $71.17 | $4.7M | 0 |
| 2020-01-02 | Davis J. E. EVP, General Diagnostics | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −77,865 | $66.51 | $5.2M | 0 |
| 2019-11-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Exercise or conversion | +11,863 | $52.17 | $619K | 51,321 |
| 2019-11-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Exercise or conversion | +32,693 | $56.12 | $1.8M | 84,014 |
| 2019-11-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −11,863 | $107.15 | $1.3M | 72,151 |
| 2019-11-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −32,193 | $107.53 | $3.5M | 39,958 |
| 2019-11-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −500 | $107.83 | $54K | 39,458 |
| 2019-11-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Exercise or conversion · Stock Options (Right to Buy) | −11,863 | $52.17 | $619K | 35,591 |
| 2019-11-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Exercise or conversion · Stock Options (Right to Buy) | −32,693 | $56.12 | $1.8M | 0 |
| 2019-11-26 | WILENSKY GAIL R Director | Exercise or conversion | +8,000 | $55.76 | $446K | 22,951 |
Page 46 of 52 · 1,040 trades